Skip to main content

Table 1 Characteristics of eligible studies

From: Comparison of atopy patch testing to skin prick testing for diagnosing mite-induced atopic dermatitis: a systematic review and meta-analysis

Study

Country

Cohort age (mean ± SD years) (range)

Number of patients (n, female/male)

Mite species (supplier)

TP

FP

FN

TN

Heinemann et al. [23]

Germany

25.4 (18–43)

52 (37/15)

D. pteronyssinus (ALK-Scherax-Arzneimittel)

13

1

10

28

Wistokat-Wülfing et al. [24]

Germany

NR

32 (NR)

D. pteronyssinus (ALK-Scherax-Arzneimittel)

14

3

7

8

Lorenzini et al. [25]

Brazil

9.47 (2–31)

43 (NR)

A. ovatus (in house)

0

6

7

30

Darsow et al. [26]

Germany

29 ± 16 (3-69)

36 (27/9)

D. pteronyssinus (Bencard, Allergopharma)

8

5

12

11

Kutlu et al. [31]

Turkey

6.9 ± 3.6 (2– 15)

44 (23/21)

D. pteronyssinus (ALK-Abello, Stallergėnes)

7

2

11

24

Manzini et al. [27]

Italy

(0.5– 63)

313 (NR)

D. pteronyssinus and D. farina (Bayropharm, Lofarma, Allergopharma

46

76

54

137

Wananukul et al. [28]

Thailand

(2–14)

30 (NR)

D. pteronyssinus (GREER)

21

0

8

1

Michel et al. [29]

Switzerland

35.8 (14–73)

23 (16/7)

D. pteronyssinus (Stallergėnes*)

6

5

5

7

Holm [22]

Sweden

29 (18–65)

81 (54/27)

D. pteronyssinus and D. farina (ALK-Abello)

14

23

5

39

Fuiano et al. [30]

Italy

2.2 ± 2.5

15 (NR)

Dermatophagoides (Stallergėnes*)

1

11

0

3

  1. NR not reported. * Stallergėnes merged with GREER in 2015